US 11395855
Exon skipping oligomer conjugates for muscular dystrophy
granted A61KA61K31/7088A61K47/549
Quick answer
US patent 11395855 (Exon skipping oligomer conjugates for muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/7088, A61K47/549, A61K47/645, A61K47/6807